EyePoint (EYPT) Tax Rate (2010 - 2026)

EyePoint (EYPT) posted Tax Rate of 0.04% for Q1 2026, up 115.07% sequentially from 0.28% in Q4 2025.

EyePoint (EYPT) Tax Rate (2010 - 2026) Analysis & Trends

EyePoint has reported Tax Rate for 10 years, with the latest figure at 0.04% in Q1 2026.

Quarterly Tax Rate changed N/A year-over-year to 0.04% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.07% (down 2.0% YoY) and the FY2025 annual result came in at 0.12%, down 5.0% from the prior year.
Tax Rate climbed to 0.04% in Q1 2026 per EYPT's latest filing, from 0.28% in the prior quarter.
Over five years, Tax Rate peaked at 0.04% in Q1 2026 and troughed at 0.28% in Q4 2025.
A 3-year average of 0.15% and a median of 0.19% in 2024 frame the typical range for Tax Rate.
The widest YoY moves for Tax Rate: up 6 bps in 2025, down 6 bps in 2025.
Over 3 years, Tax Rate stood at 0.22% in 2024, then retreated by 27 bps to 0.28% in 2025, then surged by 115 bps to 0.04% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 0.04%, 0.28%, and 0.16% for Q1 2026, Q4 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	EyePoint	1.25 Bn	1.07 Bn	507,000.00	-

Download Data